News Release

2024.10.10 Research and Development

Notification of the start of clinical development for HP-3150 (transdermal nonsteroidal pain treatment) in the U.S.

2024.10.10 lR Information

FY02/2025 Q2 Results Earnings Release Presentation

2024.10.07 Other

Notification of Open Innovation in SAGA Global Research Center

2024.07.11 lR Information

FY02/2025 Q1 Results Earnings Release Presentation

2024.07.01 Research and Development

Notification of the results of the Phase II clinical study of HP-6050 in Japan

2024.05.17 Other

Salonpas_® Named the World’s No. 1 OTC Topical Analgesic Patch Brand for the Eighth Consecutive Year

2024.04.11 lR Information

FY02/2024 Q4 Results Earnings Release Presentation

2024.03.11 Other

Notification of Completion of Construction of the New Research Laboratory “SAGA Global Research Center”

2024.02.19 Sustainability

Notice regarding Providing Relief Supplies in Response to Disaster of the 2024 Noto Peninsula Earthquake

2024.02.01 Sustainability

Notice regarding The Decision to Contribute to Supporting Organizations in FY 2023 through Hisamitsu Pharmaceutical Co., Inc. Hot Heart Club

2024.01.11 Sustainability

Notice regarding Support for Disaster of the 2024 Noto Peninsula Earthquake

2024.01.11 lR Information

Notice regarding Revision of Earnings Forecast

2024.01.11 lR Information

FY02/2024 Q3 Results Earnings Release Presentation